U.S. pharma big copyright scrapped two experimental weight loss products final 12 months—a at the time-everyday capsule, lotiglipron, on account of elevated liver enzymes along with a twice-day-to-day pill, danuglipron, due to powerful Unwanted side effects—but CEO Albert Bourla has